Application of Emergent Peripheral Mechanical Circulatory Support in Transcatheter Aortic Valve Replacement for 6 Patients
1 other identifier
observational
6
1 country
1
Brief Summary
Objective: To explore the experience of transcranial aortic valve replacement (TAVR) under emergency mechanical assisted circulation (MCS).Methods: A total of 6 patients who completed TAVR with the assistance of emergency MCS in the Second Affiliated Hospital of Zhejiang University School of Medicine from March 2013 to June 2019 were retrospectively analyzed.The management of perioperative mechanical assisted circulation, preoperative evaluation, intraoperative operation and postoperative situation of patients were summarized.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Mar 2013
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 20, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2020
CompletedFirst Submitted
Initial submission to the registry
June 28, 2020
CompletedFirst Posted
Study publicly available on registry
July 9, 2020
CompletedJuly 9, 2020
June 1, 2020
6.3 years
June 28, 2020
July 6, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
30-Day mortality rate
30-Day mortality rate
30 days after TAVR procedure
Interventions
mechanical circulatory support: cardiopulmonary bypass, extracorporeal membrane oxygenation(ECMO), left ventricular assist device
Eligibility Criteria
All patients assisted by emergency peripheral MCS during TAVR due to circulatory collapse.
You may qualify if:
- TAVR patient, assisted by emergency peripheral MCS due to circulatory collapse during TAVR
You may not qualify if:
- patients presented mechanical complications such as massive hemorrhage, coronary artery occlusion or left ventricular rupture.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Second Affiliated Hospital, School of Medicine, Zhejiang University
Hangzhou, Zhejiang, 310009, China
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 28, 2020
First Posted
July 9, 2020
Study Start
March 1, 2013
Primary Completion
June 20, 2019
Study Completion
June 1, 2020
Last Updated
July 9, 2020
Record last verified: 2020-06
Data Sharing
- IPD Sharing
- Will not share